HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon Goes To Astonishing Lengths To Boost Mascara Presence

This article was originally published in The Rose Sheet

Executive Summary

Avon Astonishing Lengths Lengthening and Defining Mascara, launching in May, is expected to strengthen the direct-seller's position in the lengthening mascara segment, the company said

You may also be interested in...



Avon 14% U.S. Beauty Sales Increase Anticipated For Second Half

Avon's U.S. beauty sales are expected to increase 14% in the second half of the year in local currency, President and Chief Financial Officer Susan Kropf predicted during the direct-seller's second quarter sales and earnings presentation to analysts July 19

Avon 14% U.S. Beauty Sales Increase Anticipated For Second Half

Avon's U.S. beauty sales are expected to increase 14% in the second half of the year in local currency, President and Chief Financial Officer Susan Kropf predicted during the direct-seller's second quarter sales and earnings presentation to analysts July 19

Anew Retroactive Skin Cream Addresses Aging Through Cell Communication

Avon's Anew Retroactive age-reversing cream uses innovative technology to "attack aging at the cellular level," the company said at a press event in New York City June 6. Debuting in October, Retroactive is the "first skin care technology to attack aging where it starts," Avon maintains.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010193

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel